Lorlatinib
CAS: 1454846-35-5
Ref. TM-T3061
1g | 878.00 € | ||
2mg | 46.00 € | ||
5mg | 67.00 € | ||
10mg | 99.00 € | ||
25mg | 147.00 € | ||
50mg | 225.00 € | ||
100mg | 393.00 € | ||
1mL*10mM (DMSO) | 69.00 € |
Product Information
- PF-6463922
- PF-06463922
- Loratinib
- (10R)-7-Amino-12-fluoro-10,15,16,17-tetrahydro-2,10,16-trimethyl-15-oxo-2H-4,8-methenopyrazolo[4,3-h][2,5,11]benzoxadiazacyclotetradecine-3-carbonitrile
- 2H-4,8-Methenopyrazolo[4,3-h][2,5,11]benzoxadiazacyclotetradecine-3-carbonitrile, 7-amino-12-fluoro-10,15,16,17-tetrahydro-2,10,16-trimethyl-15-oxo-, (10R)-
- Lorbrena
- Lorviqua
- Pf0643922
Lorlatinib (PF-6463922) is an orally available, ATP-competitive inhibitor of the receptor tyrosine kinases, anaplastic lymphoma kinase (ALK) and C-ros oncogene
Chemical properties
Technical inquiry about: TM-T3061 Lorlatinib
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.